{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:25:35Z","timestamp":1759847135992,"version":"3.41.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014840","name":"Gemeinsame Bundesausschuss","doi-asserted-by":"publisher","award":["01NVF20002"],"award-info":[{"award-number":["01NVF20002"]}],"id":[{"id":"10.13039\/501100014840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Individuals with a family history of cancer face an increased risk of developing breast and ovarian cancer. Up to 30% of the 70,000 annual breast cancer cases in Germany are associated with a familial cancer burden. Early identification of these risks is crucial as personalised measures can enable early detection or prevention of cancer. Primary care gynaecologists are uniquely suited to assess family histories and facilitate referrals to hereditary cancer centres. However, solutions on how to support early referral are still lacking. This study evaluates the impact of the digital care platform dVP_FAM as a potential remedy compared to standard care. The primary hypothesis is that the platform will increase the proportion of care-seeking women with a familial cancer risk who have not yet developed cancer. Secondary outcomes include improvements in care efficiency, patient empowerment, and health-related quality of life.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The study is a multi-centre, cluster-randomised, mixed-method trial involving 44 gynaecological centres and 800 participants recruited through hereditary\u00a0breast and ovarian cancer centres. All participants receive standard guideline-based care, while the intervention group also uses the dVP_FAM platform. The primary endpoint measures the proportion of participants with a familial cancer history who are cancer-free when seeking specialist counselling. Secondary outcomes are assessed using validated tools like the SF-12 and custom measures. Data collection employs a convergent mixed-methods approach, integrating quantitative and qualitative evidence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>The dVP_FAM platform represents an innovative approach to digitising cancer prevention in Germany, enhancing early detection and care coordination. If successful, dVP_FAM could serve as a scalable model for digital health innovations, improving efficiency and modernising the delivery of personalised care across health systems.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>German Clinical Trials Register, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/drks.de\/search\/de\/trial\/DRKS00030371\" ext-link-type=\"uri\">DRKS00030371<\/jats:ext-link>. Registered on 02 October 2023.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13063-025-08872-0","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T07:57:42Z","timestamp":1748851062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["dVP_FAM\u2014development and evaluation of a transsectoral digital care platform for individuals with familial cancer risks: study protocol for a multi-centre, cluster-randomised, mixed-methods study"],"prefix":"10.1186","volume":"26","author":[{"given":"K.","family":"Klein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Kendel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sch\u00fc\u00fcrhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Reinhold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Felbor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Stegen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Mehrhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Asmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Diel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Feufel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Speiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"8872_CR1","doi-asserted-by":"publisher","unstructured":"Meier F, Harney A, Rhiem K, Neusser S, Neumann A, Braun M, Wasem J, Huster S, Dabrock P, Schmutzler RK. Risk-Adjusted Prevention. Perspectives on the Governance of Entitlements to Benefits in the Case of Genetic (Breast Cancer) Risks. Recent Results Cancer Res. 2021;218:47\u201366. https:\/\/doi.org\/10.1007\/978-3-030-63749-1_5.","DOI":"10.1007\/978-3-030-63749-1_5"},{"key":"8872_CR2","doi-asserted-by":"publisher","unstructured":"Kast K, Rhiem K, Wappenschmidt B, Hahnen E, Hauke J, Bluemcke B, Zarghooni V, Herold N, Ditsch N, Kiechle M, Braun M, Fischer C, Dikow N, Schott S, Rahner N, Niederacher D, Fehm T, Gehrig A, Mueller-Reible C, Arnold N, Maass N, Borck G, de Gregorio N, Scholz C, Auber B, Varon-Manteeva R, Speiser D, Horvath J, Lichey N, Wimberger P, Stark S, Faust U, Weber BH, Emons G, Zachariae S, Meindl A, Schmutzler RK, Engel C, German Consortium for Hereditary B, Ovarian C. Prevalence of BRCA1\/2 germline mutations in 21 401 families with breast and ovarian cancer. J Med Genet. 2016;53(7):465\u201371. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103672.","DOI":"10.1136\/jmedgenet-2015-103672"},{"key":"8872_CR3","unstructured":"Robert Koch-Institut, Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. Krebs in Deutschland f\u00fcr 2019\/2020. Brustdr\u00fcse. 2023. Report No.: 14, 78\u201381. 15.08.2024. \nhttps:\/\/www.krebsdaten.de\/Krebs\/DE\/Content\/Publikationen\/Krebs_in_Deutschland\/krebs_in_deutschland_2023.pdf?__blob=publicationFile."},{"issue":"3","key":"8872_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/tbj.13257","volume":"25","author":"K Rhiem","year":"2019","unstructured":"Rhiem K, Bucker-Nott HJ, Hellmich M, Fischer H, Ataseven B, Dittmer-Grabowski C, Latos K, Pelzer V, Seifert M, Schmidt A, Rezek D, Groh U, Meinerz W, Crommelinck D, Hahnen E, Wesselmann S, Schmutzler RK. Benchmarking of a checklist for the identification of familial risk for breast and ovarian cancers in a prospective cohort. Breast J. 2019;25(3):455\u201360. https:\/\/doi.org\/10.1111\/tbj.13257.","journal-title":"Breast J"},{"issue":"6","key":"8872_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1159\/000533391","volume":"18","author":"D Speiser","year":"2023","unstructured":"Speiser D, Bick U. Primary Prevention and Early Detection of Hereditary Breast Cancer. Breast Care (Basel). 2023;18(6):448\u201354. https:\/\/doi.org\/10.1159\/000533391.","journal-title":"Breast Care (Basel)"},{"issue":"10","key":"8872_CR6","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.pec.2019.05.007","volume":"102","author":"D Speiser","year":"2019","unstructured":"Speiser D, Rebitschek FG, Feufel MA, Brand H, Besch L, Kendel F. Accuracy in risk understanding among BRCA1\/2-mutation carriers. Patient Educ Couns. 2019;102(10):1925\u201331. https:\/\/doi.org\/10.1016\/j.pec.2019.05.007.","journal-title":"Patient Educ Couns"},{"issue":"1","key":"8872_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/jgc4.1750","volume":"33","author":"D Speiser","year":"2024","unstructured":"Speiser D, Kendel F, Fechner K, Olbrich C, Stegen S, Haring S, Rorig A, Feufel MA. iKNOWgynetics - A web-based learning concept to empower primary care gynecologists to participate in the care of patients with a family history of breast and ovarian cancer. J Genet Couns. 2024;33(1):189\u201396. https:\/\/doi.org\/10.1002\/jgc4.1750.","journal-title":"J Genet Couns"},{"issue":"4","key":"8872_CR8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s10897-016-0040-0","volume":"26","author":"A Kne","year":"2017","unstructured":"Kne A, Zierhut H, Baldinger S, Swenson KK, Mink P, Veach PM, Tsai ML. Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter. J Genet Couns. 2017;26(4):697\u2013715. https:\/\/doi.org\/10.1007\/s10897-016-0040-0.","journal-title":"J Genet Couns"},{"issue":"5","key":"8872_CR9","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/AOG.0b013e3181da08d7","volume":"115","author":"LA Meyer","year":"2010","unstructured":"Meyer LA, Anderson ME, Lacour RA, Suri A, Daniels MS, Urbauer DL, Nogueras-Gonzalez GM, Schmeler KM, Gershenson DM, Lu KH. Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities. Obstet Gynecol. 2010;115(5):945\u201352. https:\/\/doi.org\/10.1097\/AOG.0b013e3181da08d7.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"8872_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s12687-012-0090-4","volume":"3","author":"E van Riel","year":"2012","unstructured":"van Riel E, van Dulmen S, Ausems MG. Who is being referred to cancer genetic counseling? Characteristics of counselees and their referral. J Community Genet. 2012;3(4):265\u201374. https:\/\/doi.org\/10.1007\/s12687-012-0090-4.","journal-title":"J Community Genet"},{"key":"8872_CR11","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s12312-021-01006-y","volume":"36","author":"C Breidenbach","year":"2021","unstructured":"Breidenbach C, Wesselmann S, Schult S, Rhiem K, Schmeler KM. Online-basierte Fortbildung zu famili\u00e4rem Brust- und Eierstockkrebs. Forum. 2021;36:438\u201340. https:\/\/doi.org\/10.1007\/s12312-021-01006-y.","journal-title":"Forum."},{"key":"8872_CR12","doi-asserted-by":"publisher","unstructured":"Haga SB, Kim E, Myers RA, Ginsburg GS. Primary Care Physicians' Knowledge, Attitudes, and Experience with Personal Genetic Testing. J Pers Med. 2019;9(2). https:\/\/doi.org\/10.3390\/jpm9020029.","DOI":"10.3390\/jpm9020029"},{"key":"8872_CR13","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1200\/EDBK_238937","volume":"39","author":"SA Cohen","year":"2019","unstructured":"Cohen SA, Bradbury A, Henderson V, Hoskins K, Bednar E, Arun BK. Genetic Counseling and Testing in a Community Setting: Quality, Access, and Efficiency. Am Soc Clin Oncol Educ Book. 2019;39:e34\u201344. https:\/\/doi.org\/10.1200\/EDBK_238937.","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"8872_CR14","doi-asserted-by":"publisher","first-page":"e41179","DOI":"10.2196\/41179","volume":"7","author":"D Speiser","year":"2023","unstructured":"Speiser D, Heibges M, Besch L, Hilger C, Keinert M, Klein K, Rauwolf G, Schmid C, Schulz-Niethammer S, Stegen S, Westfal V, Witzel I, Zang B, Kendel F, Feufel MA. Paradigmatic Approach to Support Personalized Counseling With Digital Health (iKNOW). JMIR Form Res. 2023;7: e41179. https:\/\/doi.org\/10.2196\/41179.","journal-title":"JMIR Form Res"},{"key":"8872_CR15","unstructured":"Besch L, Hilger C, Speiser D, Feufel MA, Kendel F. Online-gest\u00fctzte Beratungstools f\u00fcr BRCA1\/2-Mutationstr\u00e4gerinnen. Journal Onkologie. 2020;9:54\u20139."},{"key":"8872_CR16","unstructured":"Creswell JW, Plano Clark VL. Designing and Conducting Mixed Methods Research. California: SAGE, Thousand Oaks; 2018."},{"key":"8872_CR17","unstructured":"\u00c4rztekammer Westfalen-Lippe, Deutsche Krebsgesellschaft, Deutsche Gesellschaft f\u00fcr Senologie, Deutsches Konsortium f\u00fcr Erblichen Brust- und Eierstockkrebs. Checkliste zur Erfassung einer m\u00f6glichen erblichen Belastung f\u00fcr Brust- und\/oder Eierstockkrebs 2023. https:\/\/www.krebsgesellschaft.de\/zertdokumente.html?file=files\/dkg\/deutsche-krebsgesellschaft\/content\/pdf\/Zertifizierung\/Erhebungs-und-Kennzahlenboegen\/Brustkrebszentrum\/checkliste_erbliche_belastung_brust_gyn-230206.xlsx&cid=116700, Accessed 28.10.2024."},{"key":"8872_CR18","doi-asserted-by":"publisher","unstructured":"Klein K, Mehrhof N, Kendel F, Feufel MA, Speiser D, Kowalski C. Fr\u00fchzeitige Identifikation einer famili\u00e4ren Krebsbelastung. dVP_FAM \u2013 Entwicklung und Evaluation einer digitalen transsektoralen Versorgungsplattform f\u00fcr Personen mit famili\u00e4rem Krebsrisiko. Forum. 2024:1\u20134. https:\/\/doi.org\/10.1007\/s12312-024-01334-9.","DOI":"10.1007\/s12312-024-01334-9"},{"issue":"5","key":"8872_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1399-0004.2011.01636.x","volume":"79","author":"M McAllister","year":"2011","unstructured":"McAllister M, Wood AM, Dunn G, Shiloh S, Todd C. The Genetic Counseling Outcome Scale: a new patient-reported outcome measure for clinical genetics services. Clin Genet. 2011;79(5):413\u201324. https:\/\/doi.org\/10.1111\/j.1399-0004.2011.01636.x.","journal-title":"Clin Genet"},{"key":"8872_CR20","unstructured":"Bullinger M, Kirchberger I. Fragebogen zum Allgemeinen Gesundheitszustand SF 12 (Kurzform). In: Morfeld M, Kirchberger I, Bullinger M, editors. SF-36 Fragebogen zum Gesundheitszustand. G\u00f6ttingen: Hogrefe; 2011."},{"key":"8872_CR21","doi-asserted-by":"publisher","unstructured":"Wirtz MA, Morfeld M, Glaesmer H, Br\u00e4hler E. Konfirmatorische Pr\u00fcfung der Skalenstruktur des SF-12 Version 2.0 in einer deutschen bev\u00f6lkerungs-repr\u00e4sentativen Stichprobe. Diagnostica. 2018;64:84\u201396. https:\/\/doi.org\/10.1026\/0012-1924\/a000194.","DOI":"10.1026\/0012-1924\/a000194"},{"key":"8872_CR22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware","year":"1996","unstructured":"Ware J, Kosinski M, Keller S. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Car. 1996;34:220\u201333. https:\/\/doi.org\/10.1097\/00005650-199603000-00003.","journal-title":"Med Car"},{"issue":"4","key":"8872_CR23","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/ijc.30123","volume":"139","author":"F Kendel","year":"2016","unstructured":"Kendel F, Helbig L, Neumann K, Herden J, Stephan C, Schrader M, Gaissmaier W. Patients\u2019 perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy. Int J Cancer. 2016;139(4):749\u201353. https:\/\/doi.org\/10.1002\/ijc.30123.","journal-title":"Int J Cancer"},{"key":"8872_CR24","unstructured":"Buchholz A, H\u00f6lzel L, Levente K, Simon D, H\u00e4rter M. German-language version of Decisional Conflict Scale (DCS-D). Dimensional structure in a sample of family physician patients. Zeitschrift f\u00fcr Klinische Psychologie und Psychotherapie. 2011;4:15\u201330."},{"issue":"1","key":"8872_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/0272989X9501500105","volume":"15","author":"AM O'Connor","year":"1995","unstructured":"O\u2019Connor AM. Validation of a decisional conflict scale. Med Decis Making. 1995;15(1):25\u201330. https:\/\/doi.org\/10.1177\/0272989X9501500105.","journal-title":"Med Decis Making"},{"key":"8872_CR26","unstructured":"O'Connor AM. User Manual - Decision regret Scale Ottawa: Ottawa Hospital Research Institute; 2003 [1996]. https:\/\/decisionaid.ohri.ca\/docs\/develop\/User_Manuals\/UM_Regret_Scale.pdf, Accessed 28.10.2024."},{"key":"8872_CR27","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/10447318.2018.1456150","volume":"35","author":"T Franke","year":"2019","unstructured":"Franke T, Attig C, Wessel D. Personal Resource for Technology Interaction: Development and Validation of the Affinity for Technology Interaction (ATI) Scale. International Journal of Human-Computer Interaction. 2019;35:456\u201367. https:\/\/doi.org\/10.1080\/10447318.2018.1456150.","journal-title":"International Journal of Human-Computer Interaction"},{"issue":"7","key":"8872_CR28","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1177\/1359105308095063","volume":"13","author":"M McAllister","year":"2008","unstructured":"McAllister M, Payne K, Macleod R, Nicholls S, Dian D, Davies L. Patient empowerment in clinical genetics services. J Health Psychol. 2008;13(7):895\u2013905. https:\/\/doi.org\/10.1177\/1359105308095063.","journal-title":"J Health Psychol"},{"key":"8872_CR29","unstructured":"Klein K, Thomas P, Sch\u00fc\u00fcrhuis S, Kendel F. Die deutsche Version der \"Genetic Counseling Outcome Scale (GCOS-24)\": \u00dcbersetzung und Pretest eines Instruments zur Untersuchung des Patient-Empowerments von Personen mit famili\u00e4rem Krebsrisiko. Gesundheit und Klima \u2013 EbM f\u00fcr die Zukunft 24 Jahrestagung des Netzwerks Evidenzbasierte Medizin; Potsdam: German Medical Science GMS Publishing House; 2023."},{"key":"8872_CR30","doi-asserted-by":"crossref","unstructured":"Helms M, Kalmbach N, Neeb C, Kussmaul J, Speiser D. Counseling for Hereditary Breast and Ovarian Cancer at Charit\u00e9 - Characteristics of the Counselees. In: Hochhaus A, editor. Oncology Research and Treatment. Berlin: Karger; 2020.","DOI":"10.26226\/morressier.5fa3ee5d55b1fd4cc4dd938b"},{"key":"8872_CR31","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: 2023. \nwww.R-project.org."},{"key":"8872_CR32","doi-asserted-by":"crossref","unstructured":"Mayring P. Qualitative Inhaltsanalyse: Grundlagen und Techniken: Beltz P\u00e4dagogik; 2022.","DOI":"10.1007\/978-3-658-37985-8_43"},{"key":"8872_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17439760.2016.1262613","volume":"12","author":"V Clarle","year":"2016","unstructured":"Clarle V, Braun V. Thematic analysis. J Posit Psychol. 2016;12:1\u20132. https:\/\/doi.org\/10.1080\/17439760.2016.1262613.","journal-title":"J Posit Psychol"},{"issue":"2","key":"8872_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2008","unstructured":"Braun V, Clarle V. Using thematic analysis in psychology. Qual Res Psychol. 2008;3(2):77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa.","journal-title":"Qual Res Psychol"},{"key":"8872_CR35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11577-017-0456-z","volume":"69","author":"U Kuckartz","year":"2017","unstructured":"Kuckartz U. Datenanalyse in der Mixed-Methods-Forschung Z Soziol. 2017;69:157\u201383. https:\/\/doi.org\/10.1007\/s11577-017-0456-z.","journal-title":"Datenanalyse in der Mixed-Methods-Forschung Z Soziol"},{"issue":"6","key":"8872_CR36","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1370\/afm.1865","volume":"13","author":"TC Guetterman","year":"2015","unstructured":"Guetterman TC, Fetters MD, Creswell JW. Integrating Quantitative and Qualitative Results in Health Science Mixed Methods Research Through Joint Displays. Ann Fam Med. 2015;13(6):554\u201361. https:\/\/doi.org\/10.1370\/afm.1865.","journal-title":"Ann Fam Med"},{"issue":"6 Pt 2","key":"8872_CR37","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1111\/1475-6773.12117","volume":"48","author":"MD Fetters","year":"2013","unstructured":"Fetters MD, Curry LA, Creswell JW. Achieving integration in mixed methods designs-principles and practices. Health Serv Res. 2013;48(6 Pt 2):2134\u201356. https:\/\/doi.org\/10.1111\/1475-6773.12117.","journal-title":"Health Serv Res"},{"key":"8872_CR38","unstructured":"van Burren S. Flexible Imputation of Missing Data (Chapman & Hall\/CRC Interdisciplinary Statistics): CRC Press; 2018."},{"key":"8872_CR39","unstructured":"Mehrhof N, Klein K, Mangum T, Lotz B, Saadat Sarmadi S, Sch\u00fc\u00fcrhuis S, Stegen S, Wesselmann S, Wagner JK, Kendel F, Feufel M, Speiser D. iSCREEN: Digitales Screening von Personen mit einer famili\u00e4ren Brust- und\/oder Eierstockkrebsbelastung. Dtsch \u00c4rzteblatt. submitted."},{"key":"8872_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.gimo.2024.101892","author":"MA Feufel","year":"2024","unstructured":"Feufel MA, Speiser D, Sch\u00fc\u00fcrhuis S, Neumann K, Keinert M, Stegen S, Rauwolf G, Heibges M, Westfal V, Besch L, Olbrich C, Klein K, Witzel I, Kendel F. iKNOW\u2014Supporting the counseling of women with hereditary risk of breast and ovarian cancer with digital technologies: A randomized controlled trial. Genetics in Medicine Open. 2024. https:\/\/doi.org\/10.1016\/j.gimo.2024.101892.","journal-title":"Genetics in Medicine Open"},{"key":"8872_CR41","unstructured":"Sachverst\u00e4ndigenrat zur Begutachtung der Entwicklung im Gesundheitswesen. Digitalisierung f\u00fcr Gesundheit. Ziele und Rahmenbedingungen eines dynamisch lernenden Gesundheitssystems. Berlin: 2021. https:\/\/www.svr-gesundheit.de\/fileadmin\/Gutachten\/Gutachten_2021\/SVR_Gutachten_2021.pdf, Accessed 28.10.2024."},{"key":"8872_CR42","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, Hrobjartsson A, Schulz KF, Parulekar WR, Krleza-Jeric K, Laupacis A, Moher D. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346: e7586. https:\/\/doi.org\/10.1136\/bmj.e7586.","journal-title":"BMJ"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08872-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-08872-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08872-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T07:57:47Z","timestamp":1748851067000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-08872-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8872"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-08872-0","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study is performed in accordance with the Helsinki Declaration and ICH guidelines to Good Clinical Practice (GCP). The approval of the ethics committee was obtained from the Charit\u00e9 as a first vote on 19 December 2022 (EA4\/160\/44), from the ethics committee of the UM Greifswald as a second vote on 5 May 2023 (BB-031\u201323) and as a third vote from the Brandenburg State Medical Association on 20 June 2023 (2023\u201366-BO). The consent forms (German) are attached to this protocol as additional file 1. It has been individually adapted for all participating study sites.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"The consent forms (German) are attached to this protocol as additional file 1. It has been individually adapted for all participating study sites.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"Katharina Klein and Christoph Kowalski are employees of the non-profit German Cancer Society, which is one of the institutions in charge of the certification system of cancer centres. All other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"185"}}